Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients

Jart H C Diris1, Christian M Hackeng, Jeroen P Kooman

  • 1Department of Clinical Chemistry, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Diris@klinchem.azm.nl

Circulation
|December 24, 2003
PubMed

Insights

Elevated cardiac troponin T (cTnT) in dialysis patients is due to kidney dysfunction causing cTnT fragmentation. These smaller cTnT fragments accumulate, leading to falsely high readings in severe renal failure.

Area of Science:

  • Biochemistry
  • Nephrology
  • Cardiology

Background:

  • Patients with severe renal dysfunction often exhibit unexplained elevations in serum cardiac troponin T (cTnT).
  • The underlying cause for these elevated cTnT levels in renal failure patients remains unclear.

Purpose of the Study:

  • To investigate whether in vivo fragmentation of cTnT can explain the elevated serum concentrations observed in patients with severe renal dysfunction.
  • To determine if kidney dysfunction leads to the accumulation of cTnT fragments.

Main Methods:

  • Serum samples from 63 hemodialysis patients were analyzed for cTnT, creatine kinase isoenzyme MB, and myoglobin.
  • A highly sensitive immunoprecipitation assay coupled with electrophoresis and Western blotting was employed to detect and characterize cTnT fragments.

Main Results:

  • cTnT fragments, ranging from 8 to 25 kDa, were detected in the serum of all 63 dialysis patients.
  • While creatine kinase isoenzyme MB levels excluded recent myocardial events in most cases (55/63), cTnT fragmentation was a universal finding.
  • The detected cTnT fragments are small enough to be cleared by healthy kidneys.

Conclusions:

  • Cardiac troponin T undergoes fragmentation in vivo.
  • Impaired renal function leads to the accumulation of these smaller cTnT fragments.
  • This accumulation of fragmented cTnT is the likely cause of unexplained elevated serum cTnT levels in patients with severe renal failure.
Abstract

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...